Your prediction
Maat Pharma S.a. Stock
There is an upward development for Maat Pharma S.a. compared to yesterday, with an increase of €0.070 (1.700%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Maat Pharma S.a. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Maat Pharma S.a. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to